Brown Brothers Harriman & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.92K Hold
164
﹤0.01% 1448
2026
Q1
$7.03K Hold
164
﹤0.01% 1422
2025
Q4
$7.19K Buy
164
+120
+273% +$4.96K ﹤0.01% 1418
2025
Q3
$1.82K Hold
44
﹤0.01% 1583
2025
Q2
$1.94K Buy
+44
New +$1.76K ﹤0.01% 1416
2022
Q3
Sell
-849
Closed -$18K 1527
2022
Q2
$18K Buy
+849
New +$17.5K ﹤0.01% 899
2019
Q4
Sell
-13
Closed 1158
2019
Q3
$0 Hold
13
﹤0.01% 1225
2019
Q2
$0 Buy
+13
New +$272 ﹤0.01% 1134
2013
Q4
Sell
-9,000
Closed -$52K 666
2013
Q3
$52K Hold
9,000
﹤0.01% 466
2013
Q2
$41K Buy
+9,000
New +$42.7K ﹤0.01% 558

Other funds holding EXEL

Brown Brothers Harriman & Co's EXEL Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Exelixis (EXEL) position steady in Q2 2026 at 164 shares worth $8.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Brown Brothers Harriman & Co first reported a position in EXEL in Q2 2013 and has held it in 10 quarters since. The position peaked at $52K in Q3 2013. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Brown Brothers Harriman & Co held 164 shares of Exelixis worth $8.92K as of Q2 2026.
  • Brown Brothers Harriman & Co left its Exelixis share count unchanged in Q2 2026.
  • Exelixis made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1448 holding.
  • Brown Brothers Harriman & Co first reported a position in Exelixis in Q2 2013 and has held it in 10 quarters since.
  • Brown Brothers Harriman & Co's Exelixis position peaked at $52K in Q3 2013.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.